WAT Stock Summary and Trading Ideas (Waters | NYSE:WAT)

Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.

Waters trades on the NYSE stock market under the symbol WAT.

As of June 12, 2026, WAT stock price declined to $355.53 with 745,789 million shares trading.

WAT has a beta of 1.26, meaning it tends to be more sensitive to market movements. WAT has a correlation of 0.12 to the broad based SPY ETF.

WAT has a market cap of $34.87 billion. This is considered a Large Cap stock.

Last quarter Waters reported $1 billion in Revenue and $2.70 earnings per share. This beat revenue expectation by $64 million and exceeded earnings estimates by $.39.

In the last 3 years, WAT traded as high as $423.56 and as low as $231.90.

The top ETF exchange traded funds that WAT belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

WAT has underperformed the market in the last year with a price return of +1.7% while the SPY ETF gained +24.1%. However, in the short term, WAT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +25.5% vs +11.6% return in SPY. But in the last 2 weeks, WAT shares have been beat by the market, returning -7.3% compared to an SPY return of -1.9%.

WAT support price is $351.55 and resistance is $367.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WAT shares will trade within this expected range on the day.